Analyses of data from the Kaplan-Meier Plotter database indicated that high levels of MAEA expression in GC patients were associated with significantly better overall and disease-free survival (OS and DFS) relative to low MAEA levels (Fig. 1A), and the same was also true in CRC patients (Fig. 1B). The gene discussed is MAEA; the disease is gastric cancer.